We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kinder Morgan (KMI) Q3 Earnings Meet, Revenues Top Estimates
Read MoreHide Full Article
Kinder Morgan, Inc. (KMI - Free Report) reported third-quarter 2020 adjusted earnings per share of 21 cents, in line with the Zacks Consensus Estimate, thanks to contributions from Gulf Coast Express (GCX) pipeline and Elba Liquefaction projects.
The bottom line, however, declined from the year-ago quarter by a penny. A plunge in demand for refined products owing to the pandemic has hurt contributions from Products Pipelines. This in turn affected the bottom line.
Kinder Morgan, Inc. Price, Consensus and EPS Surprise
Total revenues declined to $2,919 million from $3,214 million in the prior-year quarter but beat the Zacks Consensus Estimate of $2,892 million.
Segment Analysis
Natural Gas Pipelines: Adjusted earnings before depreciation, depletion and amortization expenses, including amortization of excess cost of equity investments (EBDA), in the September quarter of 2020 were down 1% to $1,082 million from $1,090 million a year ago. Lower transportation and gathering volumes of natural gas primarily hurt the segment. Notably, a decline in demand for liquefied natural gas (LNG) has prompted lower transportation volumes in Kinder Morgan Louisiana Pipeline (KMLP) and Natural Gas Pipeline of America (NGPL). However, contributions from GCX pipeline and Elba Liquefaction projects partially made up for the negative.
Products Pipelines: The segment’s adjusted EBDA in the third quarter was $269 million, reflecting a decline of 20% from $336 million a year ago. The decline in transported volumes of crude & condensate along with refined products affected the performance. A plunge in demand for refined product owing to the coronavirus pandemic was responsible for the underperformance.
Terminals: Through this segment, Kinder Morgan generated quarterly adjusted EBDA of $246 million, down 17% from the year-ago period due to divestment of interests in Kinder Morgan Canada Limited last December. Lower demand for terminal assets owing to the pandemic also led to the dismal performance.
CO2: The segment’s EBDA increased 3% to $154 million from $149 million a year ago owing to a drop in operating expenditures and increased crude prices.
Operational Highlights
Expenses related to operations and maintenance totaled $643 million, down from $668 million a year ago. Moreover, total operating costs declined to $2,100 million in the third quarter from $2,263 million in the corresponding period of 2019.
Quarterly operating income amounted to $819 million, down from $951 million a year ago.
DCF
The company’s third-quarter distributable cash flow declined to $1,085 million from $1,140 million a year ago.
Balance Sheet
As of Sep 30, 2020, Kinder Morgan reported $632 million in cash and cash equivalents. The company’s long-term debt amounted to $31,281 million at quarter-end. Total debt-to-capitalization ratio at the end of the third quarter was 51.1%.
2020 Guidance
Kinder Morgan projects 2020 DCF lower by a little more than 10% from the initial guidance of $5.1 billion, thanks to dented energy demand and low commodity prices owing to the pandemic. The virus outbreak also compelled the company to anticipate a decline in adjusted EBITDA for 2020 of a little more than 8% from the initial guidance of $7.6 billion.
Notably, the midstream energy giant relies on its strong and stable business model and expects to pay 2020 dividend payments and discretionary spending from its internally generated cashflow. The company added that from the initial guidance, its 2020 combined expenses and sustaining capital expenditures have been reduced by a total of roughly $175 million.
Equinor has seen upward earnings estimate revision for 2020 in the past 30 days.
Sunoco has seen upward estimate revision for its 2020 bottom line in the past 30 days.
Summit Midstream has seen upward estimate revision for its 2021 bottom line in the past 30 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Kinder Morgan (KMI) Q3 Earnings Meet, Revenues Top Estimates
Kinder Morgan, Inc. (KMI - Free Report) reported third-quarter 2020 adjusted earnings per share of 21 cents, in line with the Zacks Consensus Estimate, thanks to contributions from Gulf Coast Express (GCX) pipeline and Elba Liquefaction projects.
The bottom line, however, declined from the year-ago quarter by a penny. A plunge in demand for refined products owing to the pandemic has hurt contributions from Products Pipelines. This in turn affected the bottom line.
Kinder Morgan, Inc. Price, Consensus and EPS Surprise
Kinder Morgan, Inc. price-consensus-eps-surprise-chart | Kinder Morgan, Inc. Quote
Total revenues declined to $2,919 million from $3,214 million in the prior-year quarter but beat the Zacks Consensus Estimate of $2,892 million.
Segment Analysis
Natural Gas Pipelines: Adjusted earnings before depreciation, depletion and amortization expenses, including amortization of excess cost of equity investments (EBDA), in the September quarter of 2020 were down 1% to $1,082 million from $1,090 million a year ago. Lower transportation and gathering volumes of natural gas primarily hurt the segment. Notably, a decline in demand for liquefied natural gas (LNG) has prompted lower transportation volumes in Kinder Morgan Louisiana Pipeline (KMLP) and Natural Gas Pipeline of America (NGPL). However, contributions from GCX pipeline and Elba Liquefaction projects partially made up for the negative.
Products Pipelines: The segment’s adjusted EBDA in the third quarter was $269 million, reflecting a decline of 20% from $336 million a year ago. The decline in transported volumes of crude & condensate along with refined products affected the performance. A plunge in demand for refined product owing to the coronavirus pandemic was responsible for the underperformance.
Terminals: Through this segment, Kinder Morgan generated quarterly adjusted EBDA of $246 million, down 17% from the year-ago period due to divestment of interests in Kinder Morgan Canada Limited last December. Lower demand for terminal assets owing to the pandemic also led to the dismal performance.
CO2: The segment’s EBDA increased 3% to $154 million from $149 million a year ago owing to a drop in operating expenditures and increased crude prices.
Operational Highlights
Expenses related to operations and maintenance totaled $643 million, down from $668 million a year ago. Moreover, total operating costs declined to $2,100 million in the third quarter from $2,263 million in the corresponding period of 2019.
Quarterly operating income amounted to $819 million, down from $951 million a year ago.
DCF
The company’s third-quarter distributable cash flow declined to $1,085 million from $1,140 million a year ago.
Balance Sheet
As of Sep 30, 2020, Kinder Morgan reported $632 million in cash and cash equivalents. The company’s long-term debt amounted to $31,281 million at quarter-end. Total debt-to-capitalization ratio at the end of the third quarter was 51.1%.
2020 Guidance
Kinder Morgan projects 2020 DCF lower by a little more than 10% from the initial guidance of $5.1 billion, thanks to dented energy demand and low commodity prices owing to the pandemic. The virus outbreak also compelled the company to anticipate a decline in adjusted EBITDA for 2020 of a little more than 8% from the initial guidance of $7.6 billion.
Notably, the midstream energy giant relies on its strong and stable business model and expects to pay 2020 dividend payments and discretionary spending from its internally generated cashflow. The company added that from the initial guidance, its 2020 combined expenses and sustaining capital expenditures have been reduced by a total of roughly $175 million.
Zacks Rank & Stock to Consider
The company currently has a Zacks Rank #3 (Hold). Meanwhile, a few better-ranked players in the energy space include Equinor ASA (EQNR - Free Report) , Sunoco LP (SUN - Free Report) and Summit Midstream Partners, LP (SMLP - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Equinor has seen upward earnings estimate revision for 2020 in the past 30 days.
Sunoco has seen upward estimate revision for its 2020 bottom line in the past 30 days.
Summit Midstream has seen upward estimate revision for its 2021 bottom line in the past 30 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>